EPISODE · Apr 22, 2020 · 24 MIN
9 | Cushing's Disease in Horses
from Feed Room Chemist: An Equine Nutrition Podcast · host Dr. Jyme Nichols
Today is all about Pituitary Pars Intermedia Dysfunction (PPID), or Cushing’s Disease in horses. Horses with PPID typically have a long hair coat that doesn’t shed in the spring and summer. They may be underweight, have increased drinking and urination, and be dealing with laminitis. Providing adequate medication (as directed by your veterinarian) and a low starch diet are critical to proper management. Listen to the episode to learn more! Show Notes: Author’s pick on nutritional products to support a horse with Cushing’s Syndrome · Intensify® Ex-Factor® Low Starch – 10% NSC, high fat, extruded feed. · Intensify® Senior Therapy® – 12% NSC, High fat, high fiber, pelleted feed. Dr. Jyme Nichols is Director of Nutrition for Bluebonnet Feeds and Stride Animal Health. For more information on these brands or a free virtual nutrition consult just click here!
What this episode covers
Today is all about Pituitary Pars Intermedia Dysfunction (PPID), or Cushing’s Disease in horses. Horses with PPID typically have a long hair coat that doesn’t shed in the spring and summer. They may be underweight, have increased drinking and urination, and be dealing with laminitis. Providing adequate medication (as directed by your veterinarian) and a low starch diet are critical to proper management. Listen to the episode to learn more! Show Notes: Author’s pick on nutritional products to support a horse with Cushing’s Syndrome · Intensify® Ex-Factor® Low Starch – 10% NSC, high fat, extruded feed. · Intensify® Senior Therapy® – 12% NSC, High fat, high fiber, pelleted feed. Dr. Jyme Nichols is Director of Nutrition for Bluebonnet Feeds and Stride Animal Health. For more information on these brands or a free virtual nutrition consult just click here!
NOW PLAYING
9 | Cushing's Disease in Horses
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m